Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion type Assertion NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_head.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion description "[As patients with insulin-treated IDDM frequently experience problems with hypoglycaemia, and as amylin acts to modulate the action of insulin in various tissues, it is possible that amylin deficiency may contribute to morbidity in insulin-treated IDDM, perhaps through the loss of a natural damping mechanism which guards against hypoglycaemia under conditions of normal physiology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion evidence source_evidence_literature NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion SIO_000772 2690958 NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion wasDerivedFrom befree-2016 NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.
- NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_assertion wasGeneratedBy ECO_0000203 NP1296144.RAsJ2-xJEeW-8zAbQLgeJpDRMVCzsl0C6Fg0-PH9bSUec130_provenance.